asenapine
Asenapine has been approved by the FDA for the acute treatment of adults with schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.. Reference standards of Asenapine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Asenapine Maleate (IPRS/18/14)-from IPC
[catalogue_number] => PA IPIPRS 18 14
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => asenapine-maleate-iprs-18-14-paipiprs1814
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Asenapine Maleate (IPRS/18/14)-from IPC
